Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.


TSXV:RX - Post by User

Post by overnouton Nov 26, 2020 9:10am
812 Views
Post# 31977420

3 Suggestions For The Cash

3 Suggestions For The Cash1. Use it all to buy back shares. (mostly joking)
- this would reduce all outstanding shares to just under 10M and the float to 7M. Large boost to Return on Equity as the cash pays close to zero at today's rates.

2. Acquire an Accretive Business
- I'm sure this is on the radar, but attractive targets are probably not easy to find and would have to be in the cash values present price range as I don't believe Rene likes debt even at these interest rates. (I could be wrong though)

3. Pay a Dividend (my favourite)
- Could be a one time payment (up to $1) which would be fun, but not the most beneficial action. However, an annual dividend at .20c (.05c quarterly) could easily be replaced annually by cashflow and would begin to help the declining return on Equity numbers.

Any other thoughts out there?

overnout 
<< Previous
Bullboard Posts
Next >>